<?xml version = '1.0' encoding = 'UTF-8'?><STUDY_SET>
   <STUDY alias="Comparing_sequencing_four_proto-typical_Burkitt_lymphomas_BL_IG-MYC_translocation" accession="ERP001363" center_name="DKFZ-IBIOS" broker_name="EGA">
      <IDENTIFIERS>
         <PRIMARY_ID>ERP001363</PRIMARY_ID>
         <SUBMITTER_ID namespace="DKFZ-IBIOS">Comparing_sequencing_four_proto-typical_Burkitt_lymphomas_BL_IG-MYC_translocation</SUBMITTER_ID>
      </IDENTIFIERS>
      <DESCRIPTOR>
         <CENTER_PROJECT_NAME/>
         <STUDY_TITLE>Comparing sequencing of four proto-typical Burkitt lymphomas (BL) with IG-MYC translocation.</STUDY_TITLE>
         <STUDY_TYPE existing_study_type="Whole Genome Sequencing"/>
         <STUDY_ABSTRACT>By whole-genome, exome, transcriptome and methylome sequencing of four proto-typical Burkitt lymphomas (BL) with IG-MYC translocation we identified seven recurrently mutated genes including ID3. In an extended cohort, 36/53 (68%) molecularly-defined BL carried potentially damaging mutations of ID3 which were enriched at somatic hypermutation motifs. Only 6/47 (13%) other IG-MYC-positive B-cell lymphomas carried ID3 mutations suggesting cooperation of ID3 inactivation and IG-MYC translocation to be a hallmark of Burkitt lymphomagenesis.</STUDY_ABSTRACT>
      </DESCRIPTOR>
      <STUDY_ATTRIBUTES>
         <STUDY_ATTRIBUTE>
            <TAG>ENA-SUBMISSION-TOOL</TAG>
            <VALUE>SRA-Webin</VALUE>
         </STUDY_ATTRIBUTE>
      </STUDY_ATTRIBUTES>
   </STUDY>
</STUDY_SET>